(Q40207567)

18 September 2017

High-content fluorescence-based screening for epigenetic modulators (English)

1 reference

18 September 2017

4

Gordon L Hager

1 reference

18 September 2017

Elisabeth D Martinez

1

1 reference

18 September 2017

Angie B Dull

series ordinal

2

1 reference

18 September 2017

John A Beutler

series ordinal

3

1 reference

18 September 2017

language of work or name

English

0 references

publication date

1 January 2006

1 reference

18 September 2017

Methods in Enzymology

1 reference

18 September 2017

414

1 reference

18 September 2017

21-36

1 reference

Epigenetic reactivation of tumor suppressor genes by a novel small-molecule inhibitor of human DNA methyltransferases.

18 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2914002-1

7 January 2021

Response to histone deacetylase inhibition of novel PML/RARalpha mutants detected in retinoic acid-resistant APL cells

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2914002-1

7 January 2021

The LAZ3(BCL-6) oncoprotein recruits a SMRT/mSIN3A/histone deacetylase containing complex to mediate transcriptional repression.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2914002-1

7 January 2021

Analysis of chromatin-immunopurified MeCP2-associated fragments

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2914002-1

7 January 2021

Studying nuclear receptors with green fluorescent protein fusions

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2914002-1

7 January 2021

Multidimensional chemical genetic analysis of diversity-oriented synthesis-derived deacetylase inhibitors using cell-based assays

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2914002-1

7 January 2021

DNA methylation in haematological malignancies: the role of decitabine

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2914002-1

7 January 2021

Histone-deacetylase inhibitors: novel drugs for the treatment of cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2914002-1

7 January 2021

Phase I study of an oral histone deacetylase inhibitor, suberoylanilide hydroxamic acid, in patients with advanced cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2914002-1

7 January 2021

Fusion of MOZ and p300 histone acetyltransferases in acute monocytic leukemia with a t(8;22)(p11;q13) chromosome translocation

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2914002-1

7 January 2021

DNA hypermethylation status of multiple genes in prostate adenocarcinomas

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2914002-1

7 January 2021

Expression and functional characterization of recombinant human HDAC1 and HDAC3.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2914002-1

7 January 2021

Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2914002-1

7 January 2021

Selective association of the methyl-CpG binding protein MBD2 with the silent p14/p16 locus in human neoplasia

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2914002-1

7 January 2021

An estrogen receptor chimera senses ligands by nuclear translocation

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2914002-1

7 January 2021

Histone deacetylase inhibitors open new doors in cancer therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2914002-1

7 January 2021

Increased DNA methyltransferase expression in leukaemia

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2914002-1

7 January 2021

Expression of DNA methyltransferases DNMT1, 3A, and 3B in normal hematopoiesis and in acute and chronic myelogenous leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2914002-1

7 January 2021

5' CpG island hypermethylation is associated with transcriptional silencing of the p21(CIP1/WAF1/SDI1) gene and confers poor prognosis in acute lymphoblastic leukemia

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2914002-1

7 January 2021

Phase I and pharmacokinetic study of MS-275, a histone deacetylase inhibitor, in patients with advanced and refractory solid tumors or lymphoma

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2914002-1

7 January 2021

Kinetics and comparative reactivity of human class I and class IIb histone deacetylases

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2914002-1

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2914002-1

7 January 2021

A genomic screen for genes upregulated by demethylation and histone deacetylase inhibition in human colorectal cancer

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2914002-1

7 January 2021

Histone deacetylase inhibitors in cancer treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2914002-1

7 January 2021

Histone deacetylase inhibitors: understanding a new wave of anticancer agents

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2914002-1

7 January 2021

Therapeutic targeting of transcription in acute promyelocytic leukemia by use of an inhibitor of histone deacetylase.

1 reference

https://api.crossref.org/works/10.1016%2FS0076-6879%2806%2914002-1

7 January 2021

10.1016/S0076-6879(06)14002-1

Identifiers

DOI

1 reference

18 September 2017

1 reference